Drawing for ALTEA THERAPEUTICS

USPTO serial 78184568

ALTEA THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 3493784Status 710
Filing date
Status date
Registration date
Aug 26, 2008
Examiner
EISINGER, REBECCA MILES
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ALTEA THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth M. Fox

Elizabeth M. Fox King & Spalding1180 Peachtree Street N.E.ATLANTA, GA 30309UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Transdermal drug delivery patches, sold with conventional drugs, proteins, peptides, genetic material, vaccines and live viral vectors, for use in the treatment and prevention of diabetes, endocrine and metabolic disorders, infectious diseases, acute and chronic pain caused by injury, surgery, cancer, and other causes, cardiovascular diseases and hematological disorders, neurological disorders, gastro-intestinal disease and neoplastic disease; transdermal drug delivery patch systems, sold with conventional drugs, proteins, peptides, genetic material, vaccines and live viral vectors, and comprised primarily of transdermal patch containing medicine, for use in the treatment and prevention of diabetes, endocrine and metabolic disorders, infectious diseases, acute and chronic pain caused by injury, surgery, cancer, and other causes, cardiovascular diseases and hematological disorders, neurological disorders, gastro-intestinal disease and neoplastic diseaseSECTION 8 - CANCELLEDApr 10, 2006
010Transdermal drug delivery patches sold without medicationSECTION 8 - CANCELLEDApr 10, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 27, 2015C8..CANCELLED SEC. 8 (6-YR)—
Nov 23, 2011ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 6, 2011ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 26, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2008REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Jul 21, 2008ALIEASSIGNED TO LIE—
Jul 21, 2008CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 21, 2008SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 21, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 10, 2008IUAFUSE AMENDMENT FILED—
Jul 10, 2008EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 11, 2008EX5GSOU EXTENSION 5 GRANTED—
Feb 19, 2008EXT5SOU EXTENSION 5 FILED—
Feb 19, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2008DOCKASSIGNED TO EXAMINER—
Sep 17, 2007EX4GSOU EXTENSION 4 GRANTED—
Aug 13, 2007EXT4SOU EXTENSION 4 FILED—
Aug 13, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 8, 2007EX3GSOU EXTENSION 3 GRANTED—
Jan 8, 2007EXT3SOU EXTENSION 3 FILED—
Jan 8, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 14, 2006EX2GSOU EXTENSION 2 GRANTED—
Aug 21, 2006EXT2SOU EXTENSION 2 FILED—
Aug 21, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 6, 2006EX1GSOU EXTENSION 1 GRANTED—
Feb 6, 2006EXT1SOU EXTENSION 1 FILED—
Feb 6, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 30, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 7, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 18, 2005NPUBNOTICE OF PUBLICATION—
Feb 18, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 11, 2005ALIEASSIGNED TO LIE—
Feb 7, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 13, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 22, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 22, 2004MAILPAPER RECEIVED—
Dec 15, 2004DMCCDATA MODIFICATION COMPLETED—
Nov 19, 2004MAILPAPER RECEIVED—
Nov 15, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 3, 2004GNSLLETTER OF SUSPENSION E-MAILED—
Apr 29, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 2004MAILPAPER RECEIVED—
Nov 9, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 21, 2003FAXXFAX RECEIVED—
May 1, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2003PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 21, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance